Patent Number: 8,580,258

Title: Treatment of tumors using specific anti-L1 antibody

Abstract: The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.

Inventors: Kelm; Daniela (Steinheim am der Murr, DE), Altevogt; Peter (Nekargemund, DE), Moldenhauer; Gerhard (Heidelberg, DE), Brietling; Frank (Heidelberg, DE), Krueger; Achim (Munich, DE), Wolterink; Silke (Weinheim, DE), Luettgau; Sandra (Schongau, DE), Moebius; Ulrich (Gauting, DE), Li; Yi (Wantage, GB), Sebens; Susanne (Kiel, DE), Schaefer; Heiner (Kiel, DE)

Assignee: Deutsches krebsforschungszentrum Stiftung des Offentlichen Rechts

International Classification: A61K 39/395 (20060101); A61K 39/00 (20060101)

Expiration Date: 2022-11-12 0:00:00